SIGA Technologies, Inc.

NASDAQ:SIGA

Drug Manufacturers - Specialty & Generic

Healthcare
$2.80 -0.36%

-$0.02 today

Market cap
$201.19M
Beta
0.85
P/E (TTM)
15.2
EPS (TTM)
$0.28
Dividend yield
13.97%
52W Low $4.10High $9.62

Volume 0.37M

Average 0.61M

SIGA Net Income

Bottom-line profit, the starting point for calculating cash from operations.

SIGA Technologies, Inc.NASDAQ: SIGA

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income growth accelerates

Q1 FY2026 net income of $3.45M (cash outflow) rose 746.2% year over year, ahead of the -58.3% change in trailing-twelve-month net income. Sequentially, it fell 36.4% from the prior quarter. Over 3 fiscal years it compounded at -11.8% a year.

Context

  • Net income amounted to 24.6% of revenue in FY2025, down 18.1 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 1 analysts of $121.73M (+422.9%) for the fiscal year ending Dec 2026, a step up from the -60.7% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$3.45M-36.4% QoQ
Last fiscal yearDec 2025
$23.28M-60.7% YoY
LTMMar 2026
$20.23M-58.3% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+746.2%——
1 year-60.7%+422.9%+483.6 pp
3-year CAGR-11.8%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
23.28M USD
Year-over-year change
-60.7%
4-year CAGR
-23.9%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SIGA compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -58.3% is the 6th highest of 10, against a peer median of -27.8%.
  • Net income amounts to 21.6% of revenue for SIGA, versus a peer median of 61.6%.
SIGA Competitors
Net Income for SIGA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026$364.23M USD+879.7%—121.5%
OLMAOlema Pharmaceuticals, Inc.LTM Mar 2026$185.15M USD+43.6%+15.7%—
AQSTAquestive Therapeutics, Inc.LTM Mar 2026$68.91M USD+27.1%+15.5%137.1%
CTMXCytomX Therapeutics, Inc.LTM Mar 2026$59.14M USD-242.2%-44.1%166.4%
DRIODarioHealth Corp.LTM Mar 2026$32.35M USD-27.8%-12.5%152.6%
SIGASIGA Technologies, Inc.LTM Mar 2026$20.23M USD-58.3%-11.8%21.6%
SNDLSNDL Inc.LTM Mar 2026CA$10.98M CAD-89.7%-65.1%1.2%
EBSEmergent BioSolutions Inc.LTM Mar 2026$8.6M USD-93.5%—1.3%
ESPREsperion Therapeutics, Inc.LTM Mar 2026$7.42M USD-95.2%-54.0%1.8%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026$2.72M USD+117.1%+33.6%0.5%
Peer median (excluding SIGA) —-27.8%-12.5%61.6%

Competitors are the stored peer set for SIGA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income69.45M33.9M68.07M59.21M23.28M
Depreciation & Amortization522.37K517.64K538.29K538.42K562.61K
Deferred Income Tax121.45K(3.83M)(4.8M)193.42K6.43M
Stock-Based Compensation1.27M1.78M2.05M3.64M3.68M
Change in Working Capital(60.37M)9.44M28.36M(4.69M)8.26M
Accounts Receivables(80.31M)38.24M24.28M(35.18K)17.9M
Inventory136.37K(19.96M)(25.52M)15.34M(846.31K)
Accounts Payables1.47M2.07M2M(5.74M)(578.64K)
Other Working Capital18.34M(10.91M)27.61M(14.26M)(8.22M)
Other Non-Cash Items501K(199.19K)579.24K(10.13M)1.26M
Operating Cash Flow11.49M41.61M94.8M48.76M43.47M
Capital Expenditures(50.62K)0(21.69K)(42.45K)(355.01K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(50.62K)0(21.69K)(42.45K)(355.01K)
Debt Repayment00000
Common Stock Issued00000
Common Stock Repurchased(26.02M)(13.01M)(11.07M)(799.9K)0
Dividends Paid0(32.94M)(32.14M)(42.67M)(43.12M)
Other Financing Activities(173.92K)(12.53K)(214.79K)0(433.76K)
Financing Cash Flow(26.2M)(45.96M)(43.42M)(43.46M)(43.55M)
Effect of Forex Changes00000
Net Change in Cash(14.75M)(4.35M)51.36M5.25M(433.85K)
Free Cash Flow11.44M41.61M94.78M48.72M43.12M

SIGA Technologies, Inc.

NASDAQ:SIGA

Intrinsic Alpha fair value

Locked

Current Price

$2.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.